Seeking Alpha

ChinaBio Today  

China has become the #2 pharmaceutical market years ahead of projections and continues to be the fastest growing market in the world. China is $50 billion dollars a year into life science and healthcare development through over 160 government funding programs. VC investment, M&A transactions and cross-border partnering deals in China were all up significantly in 2012.

ChinaBio® Today focuses exclusively on the rapidly evolving life science industry in China, including biotech, pharma, medical device, diagnostics, services and tools. From our offices in Shanghai and San Diego, our industry analysts provide daily news, commentary and analysis on public and private China life science companies, as well as ...More

See Seeking Alpha's policy on anonymous authors.

  • Description: Investment banker – boutique firm.
  • Interests: Developed International Markets
ChinaBio LLC ChinaBio® has established a broad platform of capabilities connecting global life science with China. As the foremost experts on the China life science industry, we have helped many large, multinational corporations as well as China domestic companies achieve success in China. We focus on consulting, ...More
ChinaBio® Today ChinaBio Today - Focused solely on China life science... China is the fastest growing market in the world for pharmaceuticals. Now, after billions of dollars of investment, China is transforming itself into a world leader in life sciences. ChinaBio® Today focuses exclusively on the rapidly evolving life ...More
Currently, you have no book details. Click edit to add book details.
Week In Review: Cross-Border Deals Dominate The Week's News Nov 24, 2014